Macrophage stimulating agent for diabetic foot ulcers

Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study Svetlana N Zykova et al Journal of Diabetes Investigation; Early View Quote: Aims/Introduction Dysregulated inflammatory response is believed to be an important factor in the pathogenesis of several late complications of diabetes mellitus. β-Glucans are potent inducers of immune function. The present randomized, double blind, two-center, placebo-controlled study was undertaken to explore safety, tolerability and efficacy of soluble β-1,3/1,6-glucan (SBG) as a local treatment of diabetic foot ulcers

Visit link:
Macrophage stimulating agent for diabetic foot ulcers

Previous post:

Next post: